# Opus Genetics, Inc.: Form 8-K, filed Mar 24, 2025

- Company: [Opus Genetics, Inc.](/companies/ird.md) (CIK 1228627)
- Form: 8-K
- Filed: 2025-03-24
- Accepted by EDGAR: Mar 24, 2025, 17:27 ET
- Period: 2025-03-21
- Accession: 0001140361-25-010064
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1228627/000114036125010064/ef20045985_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1228627/000114036125010064/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1228627/000114036125010064/ef20045985_8k.htm

Filed Mar 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-010064. Last ingested by Listed: Nov 5, 2026, 16:37 ET. No prices; not investment advice.